At a glance
ClinicalIndex Comparison RecordN/ACompleted· 64 enrolled
Drug / intervention
Contour 3D® implant for tricuspid valve repair +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Contour 3D®/TriAd® Tricuspid Annuloplasty Ring Post-Market Clinical Trial
In Brief
An observational study evaluating Contour 3D® implant for tricuspid valve repair and Tri-Ad® implant for tricuspid valve repair for Tricuspid Valve Regurgitation and Tricuspid Valve Insufficiency. Completed, enrolled 64 participants across 3 sites.
Detailed Summary
The purpose of this study is to gather clinical information on the hemodynamic performance of the Contour 3D® and Tri-Ad® Tricuspid Annuloplasty Rings in a post-market environment.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedApr 2012
Enrollment StartMay 2012
Primary CompletionJun 2016
TodayJul 2026
First PostedApr 26, 2012
Enrollment StartMay 1, 2012
Primary CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 14.2 years ago
Interventions
Contour 3D® implant for tricuspid valve repairdevice
Tricuspid annuloplasty ring
Tri-Ad® implant for tricuspid valve repairdevice
Tricuspid annuloplasty ring